News
GLP1 agonist drugs, commonly known by brand names such as Ozempic and Mounjaro, reduce asthma symptoms in obese people ...
A new study claims that GLP1 agonist drugs, commonly referred to as weight loss injections, may reduce asthma symptoms in obese people.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback